Biotechnology Instruments Market - By Product (Analytical Instruments {Spectroscopy, PCR}, Lab Automation, Sequencing Instruments, Imaging Instruments), Application (Clinical Diagnostics, Proteomics & Genomics), End-user, Global Forecast, 2023-2032

Description

List of Tables

The biotechnology instruments market is anticipated to observe more than 4.4% CAGR from 2023 to 2032. The increasing demand for advanced healthcare solutions, coupled with the rise in R&D activities, is steering the market towards unprecedented growth. The acceptance of cutting-edge technologies is redefining the landscape of scientific discovery and medical breakthroughs.

For instance, in September 2023, Waters Corporation launched the DynaPro ZetaStar instrument for nanoparticle analysis, which enables dynamic and static light scattering along with electrophoretic light scattering measurements in one device. An escalating demand for advanced healthcare solutions is propelling the market growth.

The biotechnology instruments market is classified by product, application, end-user, and region.

The lab automation instruments segment is predicted to generate massive revenues in the market by 2032. Automation is streamlining processes, enhancing precision, and accelerating experimentation, thereby reducing time and costs. Laboratories worldwide are adopting automated solutions for tasks ranging from sample handling to data analysis. This not only boosts the efficiency of R&D but also ensures reproducibility and data accuracy, laying the foundation for groundbreaking discoveries in biotechnology.

The proteomics and genomics segment will drive the market growth through 2032 as scientists delve deeper into the intricacies of life at the molecular level. Advanced biotechnology instruments enable researchers to analyze proteins and genes with unprecedented accuracy, providing insights into diseases, drug development, and personalized medicine. As genomics and proteomics enable the advancements of precision medicine, the biotechnology instruments facilitating these studies are becoming indispensable tools in laboratories worldwide.

Asia Pacific biotechnology instruments market is expected to record strong demand through 2032. Rapid economic growth, increased investment in R&D, and a growing focus on healthcare infrastructure are driving the market in this region. Countries like China, Japan, and India are at the forefront of adopting biotechnological advancements. As the Asia Pacific region embraces innovation, it is poised to become a key player in shaping the market outlook.

Product Code: 7527

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Biotechnology instruments industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Application trends
- 2.1.5 End-user trends

Chapter 3 Biotechnology Instruments Market Insights

3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic diseases
  - 3.2.1.2 Growing fundings in biotechnology industry
  - 3.2.1.3 Increasing biopharmaceutical R&D activities
  - 3.2.1.4 Technological advancements in research-use instruments
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringency of regulatory procedures
  - 3.2.2.2 Shortage of skilled professionals
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
- 3.3.3 By end-user
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022

Chapter 5 Biotechnology Instruments Market Estimates and Forecast, By Product, 2018-2032 (USD Million)

5.1 Key trends, by product
5.2 Analytical instruments
- 5.2.1 Polymerase chain reaction
- 5.2.2 Spectroscopy
- 5.2.3 Microscopy
- 5.2.4 Chromatography
- 5.2.5 Flow cytometry
- 5.2.6 Multiparameter system
- 5.2.7 Other analytical instruments
5.3 Lab automation instruments
- 5.3.1 Liquid handling systems
- 5.3.2 Robotic systems
- 5.3.3 Other lab automation products
5.4 Sequencing instruments
- 5.4.1 By technology
  - 5.4.1.1 Next-generation sequencers (NGS)
  - 5.4.1.2 Capillary electrophoresis systems
5.5 Imaging instruments
5.6 Cell analysis instruments
- 5.6.1 Centrifuge
- 5.6.2 Bioreactors
- 5.6.3 pH meter
- 5.6.4 Laminar flow
- 5.6.5 Autoclave
- 5.6.6 Other cell analysis instruments
5.7 Other products

Chapter 6 Biotechnology Instruments Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

6.1 Key trends, by application
6.2 Clinical diagnostics
6.3 Drug discovery and development
6.4 Proteomics & genomics
6.5 Cell analysis
6.6 Other applications

Chapter 7 Biotechnology Instruments Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

7.1 Key trends, by end-user
7.2 Pharmaceutical & biotechnology companies
7.3 Hospitals & diagnostic laboratories
7.4 Academic & research institutes
7.5 Other end-users

Chapter 8 Biotechnology Instruments Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Thermo Fisher Scientific, Inc.
9.2 Waters Corporation
9.3 Shimadzu Corporation
9.4 Danaher Corporation
9.5 Agilent Technologies, Inc.
9.6 Bruker Corporation
9.7 PerkinElmer, Inc.
9.8 Mettler Toledo
9.9 Zeiss Group
9.10 Bio-Rad Laboratories, Inc.
9.11 Illumina, Inc.
9.12 BIOMERIEUX S.A.
9.13 F. Hoffmann-La Roche AG
9.14 Sartorius AG
9.15 Avantor, Inc.
9.16 Eppendorf SE